PlainRecalls
FDA Drug Moderate Class II Terminated

Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg, 90-count bottles, Rx Only, Manufactured by: Actavis Elizabeth LLC, Elizabeth, NJ 07201 USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA; NDC 45963-305-09, UPC 3 45963-305-09 1.

Reported: March 11, 2015 Initiated: February 10, 2015 #D-0395-2015

Product Description

Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg, 90-count bottles, Rx Only, Manufactured by: Actavis Elizabeth LLC, Elizabeth, NJ 07201 USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA; NDC 45963-305-09, UPC 3 45963-305-09 1.

Reason for Recall

Failed Dissolution Specifications

Details

Recalling Firm
Actavis Elizabeth LLC
Units Affected
42 bottles
Distribution
Nationwide
Location
Elizabeth, NJ

Frequently Asked Questions

What product was recalled?
Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg, 90-count bottles, Rx Only, Manufactured by: Actavis Elizabeth LLC, Elizabeth, NJ 07201 USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA; NDC 45963-305-09, UPC 3 45963-305-09 1.. Recalled by Actavis Elizabeth LLC. Units affected: 42 bottles.
Why was this product recalled?
Failed Dissolution Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on March 11, 2015. Severity: Moderate. Recall number: D-0395-2015.